edoc

Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation : a pre-experimental study

Doesch, A. O. and Mueller, S. and Konstandin, M. and Celik, S. and Erbel, C. and Kristen, A. and Frankenstein, L. and Koch, A. and Dengler, T. J. and Ehlermann, P. and Zugck, C. and De Geest, S. and Katus, H. A.. (2010) Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation : a pre-experimental study. Transplantation proceedings, Vol. 42, no. 10. pp. 4238-4242.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6003812

Downloads: Statistics Overview

Abstract

Modified release tacrolimus (TAC) is a new, once-daily oral formulation of the established immunosuppressive agent TAC. Simplification of regimen has been associated with better adherence. This study evaluated patient adherence, as well as safety and efficacy among chronic stable heart transplantation (HT) patients switched from a conventional twice daily calcineurin inhibitor-based regimen (TAC or cyclosporine A [CsA]) to (once daily) modified release TAC.
Faculties and Departments:03 Faculty of Medicine > Departement Public Health > Institut für Pflegewissenschaft
UniBasel Contributors:De Geest, Sabina M.
Item Type:Article, refereed
Article Subtype:Research Article
Bibsysno:Link to catalogue
Publisher:Elsevier Science
ISSN:0041-1345
Note:Publication type according to Uni Basel Research Database: Journal article
Related URLs:
Identification Number:
Last Modified:07 Dec 2012 13:03
Deposited On:07 Dec 2012 13:01

Repository Staff Only: item control page